Hydroxychloroquine Blocks SARS-COV-2 Entry (New In-Vitro Study)

• Drbeen Medical Lectures
  Hydroxychloroquine Blocks SARS-COV-2 Entry (New in-vitro study) Supported by NIH and The US Department of Defense, this new study reveals an unknown mechanism of hydroxychloroquine to block the endocytic entry of SARS-COV-2. Let’s review. Keep in mind that this is an in-vitro, peer-reviewed, accepted, and published study.

end